Moderna Inc. has applied for full approval for its Covid-19 vaccine that was cleared on an emergency basis, the company said in a statement today.
The move could turn it into a stable source of revenue for years to come. The company further said, it will submit data to the US regulatory body on a rolling basis in coming weeks to support the application for use of the vaccine in people 18 and older.“We are pleased to announce this important step in the U.S.
regulatory process for a Biologics License Application (BLA) of our COVID-19 vaccine," said Stéphane Bancel, Chief Executive Officer of Moderna. “We look forward to working with the FDA and will continue to submit data from our Phase 3 study and complete the rolling submission."The.